Oxford Lane Capital (OXLC) Competitors $3.69 -0.06 (-1.60%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$3.70 +0.02 (+0.41%) As of 09/2/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OXLC vs. DNP, PTY, ADX, RVT, GAB, NUV, STEW, BCAT, CET, and GSBDShould you be buying Oxford Lane Capital stock or one of its competitors? The main competitors of Oxford Lane Capital include DNP Select Income Fund (DNP), Pimco Corporate & Income Opportunity Fund (PTY), Adams Diversified Equity Fund (ADX), Royce Small-Cap Trust (RVT), Gabelli Equity Trust (GAB), Nuveen Municipal Value Fund (NUV), SRH Total Return Fund (STEW), BlackRock Capital Allocation Term Trust (BCAT), Central Securities (CET), and Goldman Sachs BDC (GSBD). These companies are all part of the "financial services" industry. Oxford Lane Capital vs. Its Competitors DNP Select Income Fund Pimco Corporate & Income Opportunity Fund Adams Diversified Equity Fund Royce Small-Cap Trust Gabelli Equity Trust Nuveen Municipal Value Fund SRH Total Return Fund BlackRock Capital Allocation Term Trust Central Securities Goldman Sachs BDC Oxford Lane Capital (NASDAQ:OXLC) and DNP Select Income Fund (NYSE:DNP) are both financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Do insiders & institutionals hold more shares of OXLC or DNP? 6.7% of Oxford Lane Capital shares are owned by institutional investors. Comparatively, 8.5% of DNP Select Income Fund shares are owned by institutional investors. 3.4% of Oxford Lane Capital shares are owned by company insiders. Comparatively, 0.1% of DNP Select Income Fund shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher earnings & valuation, OXLC or DNP? Oxford Lane Capital has higher revenue and earnings than DNP Select Income Fund. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOxford Lane Capital$57.31M29.18$376.14M$0.834.45DNP Select Income FundN/AN/AN/AN/AN/A Is OXLC or DNP more profitable? Company Net Margins Return on Equity Return on Assets Oxford Lane CapitalN/A N/A N/A DNP Select Income Fund N/A N/A N/A Which has more risk and volatility, OXLC or DNP? Oxford Lane Capital has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, DNP Select Income Fund has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500. Is OXLC or DNP a better dividend stock? Oxford Lane Capital pays an annual dividend of $1.08 per share and has a dividend yield of 29.3%. DNP Select Income Fund pays an annual dividend of $0.78 per share and has a dividend yield of 7.9%. Oxford Lane Capital pays out 130.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Does the media prefer OXLC or DNP? In the previous week, DNP Select Income Fund had 2 more articles in the media than Oxford Lane Capital. MarketBeat recorded 4 mentions for DNP Select Income Fund and 2 mentions for Oxford Lane Capital. DNP Select Income Fund's average media sentiment score of 1.45 beat Oxford Lane Capital's score of 0.48 indicating that DNP Select Income Fund is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oxford Lane Capital 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DNP Select Income Fund 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOxford Lane Capital and DNP Select Income Fund tied by winning 4 of the 8 factors compared between the two stocks. Get Oxford Lane Capital News Delivered to You Automatically Sign up to receive the latest news and ratings for OXLC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OXLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OXLC vs. The Competition Export to ExcelMetricOxford Lane CapitalAsset Management IndustryFinancial SectorNASDAQ ExchangeMarket Cap$1.67B$1.43B$6.30B$9.77BDividend Yield28.80%4.56%4.29%4.50%P/E Ratio4.454,444.061,687.2626.39Price / Sales29.181,971.121,371.13110.55Price / CashN/A60.6349.0328.92Price / BookN/A1.363.696.58Net Income$376.14M$265.04M$1.23B$265.84M7 Day Performance0.82%-0.03%-0.24%-0.26%1 Month Performance6.34%1.18%2.50%5.82%1 Year Performance-30.77%6.90%27.60%22.47% Oxford Lane Capital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OXLCOxford Lane Capital1.5904 of 5 stars$3.69-1.6%N/A-31.2%$1.67B$57.31M4.45601Stock SplitDNPDNP Select Income FundN/A$9.89+0.2%N/A+3.4%$3.66BN/A0.00590News CoveragePositive NewsDividend AnnouncementPTYPimco Corporate & Income Opportunity FundN/A$14.09+0.1%N/A-0.8%$2.56BN/A0.00147,000Positive NewsADXAdams Diversified Equity FundN/A$21.60-0.2%N/A+0.3%$2.54BN/A0.0030News CoveragePositive NewsRVTRoyce Small-Cap TrustN/A$15.98+0.4%N/A+2.9%$1.91B$9.80M0.0050News CoveragePositive NewsShort Interest ↓GABGabelli Equity TrustN/A$6.01+0.1%N/A+9.2%$1.85B$203.01M0.00N/ANUVNuveen Municipal Value FundN/A$8.64-0.3%N/A-1.4%$1.79B$33.04M0.00640Positive NewsSTEWSRH Total Return FundN/A$18.20+0.0%N/A+16.0%$1.76BN/A0.00N/ABCATBlackRock Capital Allocation Term TrustN/A$14.79-0.2%N/A-10.0%$1.59B$197.67M0.00147,000Short Interest ↑CETCentral SecuritiesN/A$49.93-0.1%N/A+12.0%$1.44B$222.17M0.006Positive NewsGSBDGoldman Sachs BDC1.3246 of 5 stars$11.29-1.2%$10.00-11.4%-19.6%$1.29B$434.37M8.96N/APositive News Related Companies and Tools Related Companies DNP Select Income Fund Competitors Pimco Corporate & Income Opportunity Fund Competitors Adams Diversified Equity Fund Competitors Royce Small-Cap Trust Competitors Gabelli Equity Trust Competitors Nuveen Municipal Value Fund Competitors SRH Total Return Fund Competitors BlackRock Capital Allocation Term Trust Competitors Central Securities Competitors Goldman Sachs BDC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OXLC) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Lane Capital Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Lane Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.